EP4363449 - METHODS AND COMPOSITIONS FOR TREATING CANCER [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 05.04.2024 Database last updated on 03.08.2024 | |
Former | The international publication has been made Status updated on 06.01.2023 | ||
Former | unknown Status updated on 26.08.2022 | Most recent event Tooltip | 05.04.2024 | Publication in section I.1 EP Bulletin | published on 08.05.2024 [2024/19] | 05.04.2024 | The date on which the examining division becomes responsible, has been established | 05.04.2024 | Request for examination filed | published on 08.05.2024 [2024/19] | Applicant(s) | For all designated states GENENTECH, INC. 1 DNA Way South San Francisco, CA 94080 / US | For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [2024/19] | Inventor(s) | 01 /
MARKERT, Christoph 82377 Penzberg / DE | 02 /
MENG, Raymond, D. South San Francisco, CA 94080-4990 / US | 03 /
MUECKE, Merlind 4070 Basel / CH | 04 /
SEN, Shiraj South San Francisco, CA 94080-4990 / US | 05 /
TEICHGRAEBER, Volker 4070 Basel / CH | 06 /
WIEBKING, Volker, Andreas South San Francisco, CA 94080-4990 / US | 07 /
CHA, Edward, Namserk South San Francisco, CA 94080-4990 / US | 08 /
COTTER, Christopher, Roland South San Francisco, CA 94080-4990 / US | 09 /
DORAL, Michelle, Yuri South San Francisco, CA 94080-4990 / US | [2024/19] | Representative(s) | Klostermeyer-Rauber, Dörte, et al F. Hoffmann-La Roche AG Corporate Law Patents (CLP) Grenzacherstrasse 124 4070 Basel / CH | [2024/19] | Application number, filing date | 22755374.0 | 01.07.2022 | [2024/19] | WO2022US73365 | Priority number, date | US202163218194P | 02.07.2021 Original published format: US 202163218194 P | US202163226714P | 28.07.2021 Original published format: US 202163226714 P | US202163286525P | 06.12.2021 Original published format: US 202163286525 P | [2024/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2023279092 | Date: | 05.01.2023 | Language: | EN | [2023/01] | Type: | A2 Application without search report | No.: | EP4363449 | Date: | 08.05.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.01.2023 takes the place of the publication of the European patent application. | [2024/19] | Search report(s) | International search report - published on: | EP | 16.03.2023 | Classification | IPC: | C07K16/28, A61P35/00, C07K16/18, A61K39/00, A61P31/00, A61P35/02 | [2024/19] | CPC: |
A61P35/00 (EP,IL,KR);
A61K39/0011 (EP,IL);
C07K16/2803 (EP,IL,KR);
A61K39/12 (EP,IL);
A61P31/00 (EP,IL);
A61P35/02 (EP,IL);
C07K16/2818 (EP,IL,KR);
A61K2039/505 (EP,IL,KR);
A61K2039/507 (EP,IL);
A61K2039/5254 (EP,IL);
A61K2039/54 (EP,IL,KR);
A61K2039/545 (EP,IL,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/19] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON KREBS | [2024/19] | English: | METHODS AND COMPOSITIONS FOR TREATING CANCER | [2024/19] | French: | MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT DU CANCER | [2024/19] | Entry into regional phase | 02.02.2024 | National basic fee paid | 02.02.2024 | Designation fee(s) paid | 02.02.2024 | Examination fee paid | Examination procedure | 18.12.2023 | Amendment by applicant (claims and/or description) | 02.02.2024 | Examination requested [2024/19] | 02.02.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 15.03.2024 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2018185043 (HOFFMANN LA ROCHE [CH], et al); | [I]EP3392276 (JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD [CN], et al); | [XI]WO2020081928 (BRISTOL MYERS SQUIBB CO [US]); | [Y]WO2020251187 (GREEN CROSS CORP [KR], et al); | [Y]WO2021043206 (BIO THERA SOLUTIONS LTD [CN]); | [XI]WO2021133653 (MACROGENICS INC [US]); | [XP]WO2021154761 (GENENTECH INC [US], et al); | by applicant | US4816567 | WO8906692 | EP0404097 | WO9219579 | WO9301161 | WO9316185 | WO9410202 | WO9429351 | WO9429350 | WO9527062 | US5500362 | WO9627011 | WO9630046 | US5571894 | US5587458 | US5624821 | US5648260 | US5731168 | US5804396 | US5821337 | WO9845332 | WO9850431 | US5869046 | US6054297 | US6171586 | US6248516 | US6267958 | EP0666868 | US6582959 | US2003190317 | US2003203409 | US2003206899 | US6703020 | US6737056 | US2004132028 | WO2004056312 | US6818418 | US2005014934 | WO2005012359 | US6884879 | US2005112126 | WO2005056764 | US2005186208 | US2005260186 | US2006009360 | EP1641818 | WO2006044908 | US7060269 | WO2006121168 | WO2007005874 | US7166697 | US7250297 | US2007224633 | WO2007110205 | EP1870459 | WO2007147901 | US7332581 | US7371826 | US2008139791 | WO2008098796 | WO2009080252 | WO2009080253 | WO2009089004 | WO2009114335 | WO2009126688 | WO2010027827 | US7695936 | WO2010077634 | WO2010129304 | WO2011066389 | WO2011066342 | WO2011090754 | WO2011090762 | WO2011143545 | WO2011161699 | WO2012058768 | US8217149 | WO2012130831 | WO2012145493 | WO2012168944 | US2013034559 | WO2013096291 | WO2013132317 | WO2013144704 | WO2013157954 | WO2013157953 | WO2013181634 | WO2014179664 | WO2014194302 | WO2014206107 | WO2015033301 | WO2015033299 | WO2015033303 | WO2015036927 | WO2015035606 | WO2015044900 | WO2015085847 | WO2015112800 | WO2015112805 | WO2015112900 | US2015210769 | WO2015119930 | WO2015119923 | WO2015150447 | US9205148 | WO2016000619 | WO2016020309 | WO2016032927 | US2016108123 | WO2016061142 | WO2016089873 | WO2016106160 | US9499596 | US20010236388 | WO2016EP73408 |